Learn Tinkercad from scratch in just 9 minutes. This complete beginner-friendly tutorial guides you step by step to start creating 3D designs confidently. #Tinkercad #3DDesign #TutorialForBeginners ...

If you’ve been interested in FreeCAD but haven’t known where to start, here’s a wonderful video tutorial for FreeCAD 1.1 by [Deltahedra] aimed squarely at how to model a 3D part from scratch while ...

PTC is offering the integration between its cloud-native Onshape CAD and PDM platform and Altium, a company that provides electronic design automation (EDA) tools. The connector enables electrical and ...

BOSTON, May 12, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced a new integration between its cloud-native Onshape ® computer‑aided design (CAD) and product data management (PDM) platform and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Connects Printed Circuit Board (PCB) design from Altium directly into Onshape in a unified cloud-native workflow Eliminates file-based PCB data exchange between electrical and mechanical design ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PTC has completed the previously announced sale of the company’s Kepware industrial connectivity and ThingWorx Internet of Things (IoT) businesses to TPG, a leading global alternative asset management ...

PTC Therapeutics is transitioning its growth engine from legacy drugs to new launches like Sephience, targeting rare genetic diseases with high unmet need. Pipeline catalysts, notably Votoplam for ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...

PTC Therapeutics has abandoned its latest attempt to secure FDA approval for Duchenne muscular dystrophy (DMD) treatment Translarna, after the FDA said it was unlikely to approve the drug based on the ...

DiRico reaffirmed fiscal '26 constant currency ARR growth guidance of 7.5%–9.5% excluding Kepware and ThingWorx, and 7%–9% including them. She said, "In Q2, for constant currency ARR excluding Kepware ...